What You Should Know:
- Artera, a company developing multimodal artificial intelligence (MMAI)-based prognostic and predictive cancer tests, today announced the publication of a significant validation study in the JCO Clinical Cancer Informatics.
- The study rigorously assessed Artera's MMAI model and confirmed its ability to perform similarly across different racial subgroups using data from diverse prostate cancer clinical trials.
Addressing the Challenge of AI Racial Bias
Read More
Digital Health | News, Analysis, Insights - HIT Consultant
FDA Approves Teal Wand™: The First At-Home Self-Collection Device for Cervical Cancer Screening in the U.S.
What You Should Know:
- Teal Health®, a women's health company dedicated to eliminating cervical cancer, today announced a landmark achievement: the U.S. Food and Drug Administration (FDA) has approved the Teal Wand™, marking it as the first and only at-home self-collection device for cervical cancer screening in the United States.
- The FDA approval paves the way for women to have a new, convenient, and effective option for what is commonly known as the Pap smear,
Read More
Beyond Patient Portals: Defining the Clinician Digital Front Door
First impressions are everything. Almost everyone working in healthcare understands that. And it’s not just clinicians. The architect who designed the front lobby of a hospital or the website developer who ensures the ease of use of a health system’s digital presence understands how important that first impression is. Patients come first in healthcare, and that’s true when focusing on patient access or simply creating a welcoming environment. It is just as important to focus on the impact that
Read More
AI Shows Promise in Detecting Overlooked Breast Cancers Between Screenings, UCLA Study Reveals
What You Should Know:
- Artificial intelligence (AI) could play a crucial role in identifying breast cancers that develop between routine screening mammograms, potentially detecting them before they become more advanced and challenging to treat, according to a new study led by investigators at the UCLA Health Jonsson Comprehensive Cancer Center.
- The research suggests that integrating AI into breast cancer screening practices could lead to earlier treatment and improved
Read More
Kouper Emerges from Stealth with $10M to Transform Patient Care Transitions
What You Should Know:
- Kouper, a health technology platform engineered to revolutionize transitions of care, formally announced its launch from stealth mode, backed by $10M in funding.
- The investment round was led by General Catalyst, 25Madison, and CVS Health Ventures, aimed at supporting Kouper's mission to assist the millions of patients navigating different healthcare settings annually in the United States.
Addressing a Fraught Journey with a Personalized Approach
Kouper is
Read More
Reflexion Launches AI Platform to Democratize Mental Health Support for Underserved Communities
What You Should Know:
- Reflexion, an AI-powered platform designed to deliver accessible, self-guided emotional reflection, today announced its public release aimed at transforming early-stage mental health care.
- Developed by software engineer and emotional AI researcher Shou-Tzu Han, Reflexion leverages natural language processing (NLP), psychological prompting, and metaphorical storytelling to help users explore emotions, reframe distress, and build emotional resilience.
Reflexion:
Read More
MedTech Breakthrough Announces 2025 MedTech Breakthrough Award Winners
What You Should Know:
- MedTech Breakthrough, an independent market intelligence organization dedicated to recognizing top-tier companies, technologies, and products in the global health and medical technology sector, today proudly announced the winners of its 9th annual awards program.
- The 2025 awards highlight the groundbreaking technologies and companies that are spearheading innovation and exemplifying the best in digital health and medical technology solutions
Read More
Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density
What You Should Know:
- Osteoboost Health announced the nationwide availability of Osteoboost, a groundbreaking prescription medical device. Osteoboost aims to provide hope for millions diagnosed with low bone density, helping to reduce the risk of fractures that can severely impact mobility and independence.
- As the first and only FDA-cleared device of its kind for low bone density, Osteoboost introduces a novel, protective, and preventative approach to bone health, offering a new
Read More
Shaping the Future of Sleep Apnea Diagnostics: Enhancing Accessibility and Comfort with Wearables
Sleep is essential, yet millions worldwide unknowingly suffer from sleep disorders, especially Obstructive Sleep Apnea (OSA), which contributes to up to 40 severe health complications like cardiovascular disease, chronic fatigue, and reduced quality of life. Despite its impact, diagnosing OSA remains a challenge due to its high costs, limited access to specialized facilities, and patient discomfort towards traditional sleep studies.
Fortunately, advancements in non-invasive,
Read More
Blue Cross Blue Shield of Massachusetts Launches “CloseKnit” Virtual-First Primary Care Option
What You Should Know:
- Blue Cross Blue Shield of Massachusetts (“Blue Cross”) today announced the launch of CloseKnit, a new virtual-first primary care option designed to provide members with accessible and convenient health support.
- As part of their agreement, CloseKnit is actively participating in Blue Cross's value-based payment program, aligning with the insurer's commitment to quality and affordability while ensuring members receive timely primary care
Read More
